Showing results (1701-1710 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|April 5, 2016
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview ApproachHeather L Gelhorn, Matthew H Kulke, Thomas O'Dorisio, et al.
Clinical Therapeutics|April 5, 2016
Genomic Alterations and Targeted Therapy in Gastric and Esophageal AdenocarcinomaEirini Pectasides
Clinical Therapeutics|April 6, 2016
Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical TrialsEthan Basch, Lauren J Rogak, Amylou C Dueck
Clinical Therapeutics|March 22, 2016
Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS StudyJeong Bae Park, Joon-Han Shin, Dong-Soo Kim, et al.
Clinical Therapeutics|November 8, 2017
Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9)Maria Yu, Kate Van Brunt, Zvonko Milicevic, et al.
Clinical Therapeutics|November 8, 2017
Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European CountriesEdith M Heintjes, Jetty A Overbeek, Gillian C Hall, et al.
Clinical Therapeutics|July 19, 2015
Evaluating the Cost of Bringing People with Type 2 Diabetes Mellitus to Multiple Targets of Treatment in CanadaRasmus Skovgaard, Uffe Jon Ploug, Barnaby Hunt, et al.
Clinical Therapeutics|February 5, 2025
Real-World Effectiveness of Sotrovimab in Ambulatory Patients With COVID-19: A Retrospective Cohort Study Using a Large Administrative Claims Database in the United StatesChristopher F Bell, Tasneem Lokhandwala, Daniel C Gibbons, et al.
Clinical Therapeutics|February 4, 2025
Real-Life Efficacy and Safety of Glecaprevir/Pibrentasvir Pediatric Formulation for Chronic Hepatitis C Infection in Children Aged 3 to 12 Years: A Case Series of 6 PatientsFrancesca Musto, Marta Stracuzzi, Alessandro Cibarelli, et al.
Clinical Therapeutics|March 4, 2025
Cost-Effectiveness Analysis of SOX Plus Bevacizumab Versus SOX Plus Cetuximab for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer in JapanTakashi Morimoto, Kaori Fujito, Rei Goto
Pageof 680